We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

Infectious diseases (ID) physicians are increasingly responsible for the management of
infectious consequences of substance use disorders (SUD). While we are often consulted …

Objectives In the United States, rising rates of overdose deaths and recent outbreaks of
hepatitis C virus and HIV infection are associated with injection drug use. We updated a …

Introduction The HIV epidemic is increasingly penetrating rural areas of the US due to
evolving epidemics of injection drug use. Many rural areas experience deficits in availability …

Background Opioid agonist treatment (OAT) reduces many of the harms associated with
opioid dependence. We use mathematical modelling to comprehensively evaluate the …

Aims To examine the cost‐effectiveness of hepatitis C virus (HCV) treatment of people who
inject drugs (PWID), combined with medication‐assisted treatment (MAT) and syringe …

One of the main goals of the 2016 Global Health Sector Strategy on viral hepatitis is the
elimination of hepatitis C virus (HCV) as a public health problem by 2030, defined as an …

Background People who inject drugs (PWID) are disproportionately affected by hepatitis C
virus (HCV). Data tracking the engagement of PWID in the continuum of HCV care are …

Background Increasing rates of injection drug use (IDU) associated-infections suggest
significant syringe service program (SSP) underutilization. Our study objective was to assess …

Abstract Background Hepatitis C (HCV) is the most common infectious disease among
people who inject drugs (PWID). Engaging PWID in harm reduction services, such as …